ACADIA PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Acadia Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $26.2M, a 41.1% increase year-over-year.
  • Acadia Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $74.6M, a 18.8% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $66.4M, a 2.61% decline from 2022.
  • Acadia Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $68.2M, a 7.21% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $63.6M, a 24.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $66.4M -$1.78M -2.61% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $68.2M +$4.59M +7.21% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $63.6M -$20.8M -24.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $84.4M +$2.16M +2.62% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $82.3M +$701K +0.86% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $81.6M +$6.03M +7.99% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $75.5M +$20.3M +36.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $55.3M +$15.1M +37.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $40.2M +$24.2M +151% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $16M +$10.3M +181% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $5.71M +$3.78M +196% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $1.93M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.